216 related articles for article (PubMed ID: 18514452)
21. Blood transfusion in sports.
Giraud S; Sottas PE; Robinson N; Saugy M
Handb Exp Pharmacol; 2010; (195):295-304. PubMed ID: 20020370
[TBL] [Abstract][Full Text] [Related]
22. Blood transfusions in athletes. Old dogmas, new tricks.
Lippi G; Banfi G
Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813
[TBL] [Abstract][Full Text] [Related]
23. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods.
Luten M; Roerdinkholder-Stoelwinder B; Schaap NP; de Grip WJ; Bos HJ; Bosman GJ
Transfusion; 2008 Jul; 48(7):1478-85. PubMed ID: 18482180
[TBL] [Abstract][Full Text] [Related]
24. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.
Pottgiesser T; Sottas PE; Echteler T; Robinson N; Umhau M; Schumacher YO
Transfusion; 2011 Aug; 51(8):1707-15. PubMed ID: 21382045
[TBL] [Abstract][Full Text] [Related]
25. Autologous Doping with Cryopreserved Red Blood Cells - Effects on Physical Performance and Detection by Multivariate Statistics.
Malm CB; Khoo NS; Granlund I; Lindstedt E; Hult A
PLoS One; 2016; 11(6):e0156157. PubMed ID: 27284981
[TBL] [Abstract][Full Text] [Related]
26. American College of Sports Medicine position stand on blood doping as an ergogenic aid.
Med Sci Sports Exerc; 1987 Oct; 19(5):540-3. PubMed ID: 3316908
[TBL] [Abstract][Full Text] [Related]
27. Post-transfusion survival of biotin-labeled allogeneic RBCs in adult horses.
Mudge MC; Walker NJ; Borjesson DL; Librach F; Johns JL; Owens SD
Vet Clin Pathol; 2012 Mar; 41(1):56-62. PubMed ID: 22251607
[TBL] [Abstract][Full Text] [Related]
28. ISO/IEC 17025 Sysmex R-500 hematology reticulocyte analyzer validation.
Dimopoulou HA; Theodoridis T; Galea V; Christopoulou-Cokkinou V; Spyridaki MH; Georgakopoulos CG
Lab Hematol; 2007; 13(2):43-8. PubMed ID: 17573280
[TBL] [Abstract][Full Text] [Related]
29. Identification and quantification of fetal red blood cells in maternal blood by a dual-color flow cytometric method: evaluation of the Fetal Cell Count kit.
Porra V; Bernaud J; Gueret P; Bricca P; Rigal D; Follea G; Blanchard D
Transfusion; 2007 Jul; 47(7):1281-9. PubMed ID: 17581165
[TBL] [Abstract][Full Text] [Related]
30. Detecting Autologous Blood Transfusion in Doping Control: Biomarkers of Blood Aging and Storage Measured by Flow Cytofluorimetry.
Donati F; Acciarini R; De Benedittis I; de la Torre X; Pirri D; Prete M; Stampella A; Vernucci E; Botre F
Curr Pharm Biotechnol; 2018; 19(2):124-135. PubMed ID: 29621963
[TBL] [Abstract][Full Text] [Related]
31. Red blood cell populations and membrane levels of peroxiredoxin 2 as candidate biomarkers to reveal blood doping.
Marrocco C; Pallotta V; D'alessandro A; Alves G; Zolla L
Blood Transfus; 2012 May; 10 Suppl 2(Suppl 2):s71-7. PubMed ID: 22890272
[TBL] [Abstract][Full Text] [Related]
32. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry I. Screening analysis.
Badoud F; Grata E; Perrenoud L; Avois L; Saugy M; Rudaz S; Veuthey JL
J Chromatogr A; 2009 May; 1216(20):4423-33. PubMed ID: 19342059
[TBL] [Abstract][Full Text] [Related]
33. Qualitative detection of diuretics and acidic metabolites of other doping agents in human urine by high-performance liquid chromatography-tandem mass spectrometry: comparison between liquid-liquid extraction and direct injection.
Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT
J Chromatogr A; 2009 Jul; 1216(31):5819-27. PubMed ID: 19560151
[TBL] [Abstract][Full Text] [Related]
34. Hemoglobin mass and biological passport for the detection of autologous blood doping.
Pottgiesser T; Echteler T; Sottas PE; Umhau M; Schumacher YO
Med Sci Sports Exerc; 2012 May; 44(5):835-43. PubMed ID: 21988933
[TBL] [Abstract][Full Text] [Related]
35. Removal of Plasmodium falciparum-infected red blood cells from whole blood by leukoreduction filters.
Cardo LJ; Salata J; Wilder D
Transfusion; 2009 Feb; 49(2):337-46. PubMed ID: 19389214
[TBL] [Abstract][Full Text] [Related]
36. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease.
Ribeiro KR; Guarnieri MH; da Costa DC; Costa FF; Pellegrino J; Castilho L
Vox Sang; 2009 Aug; 97(2):147-52. PubMed ID: 19392786
[TBL] [Abstract][Full Text] [Related]
37. Screening for autologous blood transfusions.
Mørkeberg J; Belhage B; Ashenden M; Bornø A; Sharpe K; Dziegiel MH; Damsgaard R
Int J Sports Med; 2009 Apr; 30(4):285-92. PubMed ID: 19199200
[TBL] [Abstract][Full Text] [Related]
38. A quadruplex real-time qPCR assay for the simultaneous assessment of total human DNA, human male DNA, DNA degradation and the presence of PCR inhibitors in forensic samples: a diagnostic tool for STR typing.
Hudlow WR; Chong MD; Swango KL; Timken MD; Buoncristiani MR
Forensic Sci Int Genet; 2008 Mar; 2(2):108-25. PubMed ID: 19083806
[TBL] [Abstract][Full Text] [Related]
39. The age of red blood cells in premature infants (ARIPI) randomized controlled trial: study design.
Fergusson D; Hutton B; Hogan DL; LeBel L; Blajchman MA; Ford JC; Hebert P; Kakadekar A; Kovacs L; Lee S; Sankaran K; Shapiro S; Smyth JA; Ramesh K; Bouali NR; Tinmouth A; Walker R
Transfus Med Rev; 2009 Jan; 23(1):55-61. PubMed ID: 19056034
[TBL] [Abstract][Full Text] [Related]
40. Testing for recombinant erythropoietin.
Delanghe JR; Bollen M; Beullens M
Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
